All Type of News
FTC organizes research conferenceThe Free Trade Commission, Korea’s law enforcement agency, said on September 3 it will hold its 5th conference of competition authorities and international organizations such as...
|
Ilyang awaits approval for ilaprazole in KoreaIlyang Pharm is soon expecting to receive marketing approval for ilaprazole, a new investigational proton pump inhibitor, from the Korea Food and Drug Administration as the KFDA...
|
Patients to benefit from homegrown Peluvi tablet
The National Health Insurance Corporation and Daewon Pharm finally agreed on September 3 to set the insurance price of Peluvi (felubiprofen) at 208 won per tablet.
Daewon demanded the government set a minimum price...
KFDA to build database to support pharmaceutical firms
The Korea Food and Drug Administration says it plans to set up its database to facilitate effort of local pharmaceutical firms engaged in the license, patent and marketing of medicines.
The database, which will be...
W30 bil. `lip care' market steams up
As the weather gets chilly, domestic 30 billion won lip care market is set to heat up all the times.
Following the country's leading lip products – Nivea and Chapstic, Mantholatum Korea is also rushing into the gam...
3,729 items to be re-evaluated over economic effectiveness
The Health Insurance Review and Assess Service (HIRA) announced on September 2 that a total of 3,729 items from six therapeutic categories will be evaluated for their economic effectiveness within this year.
The si...
Government to streamline drug pricing policy
OTC products to be deleted from health insurance eligible category will be carefully selected to prevent “drug shift phenomenon”, according to the Ministry of Health, Welfare and Family Affairs.
In a recent forum, ...
Yungjin, Ildong face redemption suit of medication costs
The National Health Insurance Corporation filed a suit against Yungjin Pharm and Ildong Pharm, for their improper health insurance allowance claim of medicines involved in fabricated bioequivalence test results.
“T...
Pharmaceutical firms urged to nurture cGMP technicians
Domestic drug makers need to take substantial measures to nurture GMP related professionals as concern is mounting that the construction plan of cGMP plant has been stalled due to the Korea won’s drastic fall.
Ther...
New recombinant antihemophilic factor approvedGreen Cross Corporation said on September 3 that the Korea Food and Drug Administration approved its new recombinant DNA-derived clotting factor to treat people with hemophilia ...
|
